BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 29386890)

  • 1. Phenotyping COPD exacerbations using imaging and blood-based biomarkers.
    Alotaibi NM; Chen V; Hollander Z; Hague CJ; Murphy DT; Leipsic JA; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
    Int J Chron Obstruct Pulmon Dis; 2018; 13():217-229. PubMed ID: 29386890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein and N-terminal prohormone brain natriuretic peptide as biomarkers in acute exacerbations of COPD leading to hospitalizations.
    Chen YR; Chen V; Hollander Z; Leipsic JA; Hague CJ; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
    PLoS One; 2017; 12(3):e0174063. PubMed ID: 28328968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Terminal Prohormone of Brain Natriuretic Peptide (NT-proBNP) as a Diagnostic Biomarker of Left Ventricular Systolic Dysfunction in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
    Andrijevic I; Milutinov S; Lozanov Crvenkovic Z; Matijasevic J; Andrijevic A; Kovacevic T; Bokan D; Zaric B
    Lung; 2018 Oct; 196(5):583-590. PubMed ID: 29951921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers.
    Abroug F; Ouanes-Besbes L; Nciri N; Sellami N; Addad F; Hamda KB; Amor AB; Najjar MF; Knani J
    Am J Respir Crit Care Med; 2006 Nov; 174(9):990-6. PubMed ID: 16840745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction.
    Ouanes I; Jalloul F; Ayed S; Dachraoui F; Ouanes-Besbes L; Fekih Hassen M; Elatrous S; Abroug F
    Respirology; 2012 May; 17(4):660-6. PubMed ID: 22348741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD.
    Li H; Zeng Z; Cheng J; Hu G; Li Y; Wei L; Zhou Y; Ran P
    Int J Chron Obstruct Pulmon Dis; 2020; 15():57-67. PubMed ID: 32021144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung ultrasound for the evaluation of pulmonary congestion in outpatients: a comparison with clinical assessment, natriuretic peptides, and echocardiography.
    Miglioranza MH; Gargani L; Sant'Anna RT; Rover MM; Martins VM; Mantovani A; Weber C; Moraes MA; Feldman CJ; Kalil RA; Sicari R; Picano E; Leiria TL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1141-51. PubMed ID: 24094830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction.
    Adrish M; Nannaka VB; Cano EJ; Bajantri B; Diaz-Fuentes G
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1183-1189. PubMed ID: 28458528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure.
    Yao C; Wang L; Shi F; Chen R; Li B; Liu W; Feng M; Li S
    Int J Med Sci; 2021; 18(7):1592-1599. PubMed ID: 33746575
    [No Abstract]   [Full Text] [Related]  

  • 11. NT-pro BNP in AECOPD-PH: old biomarker, new insights-based on a large retrospective case-controlled study.
    Tian F; Song W; Wang L; Zeng Q; Zhao Z; Feng N; Fan J; Wang Y; Wang J; Ma X
    Respir Res; 2021 Dec; 22(1):321. PubMed ID: 34961527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term treatment of irbesartan and hydrochlorothiazide decreases plasma N-terminal pro-brain natriuretic peptide levels in subjects with acute exacerbations of COPD.
    Jiang GY; Li Q; Lv YX
    Int J Chron Obstruct Pulmon Dis; 2019; 14():73-80. PubMed ID: 30587963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort.
    Labaki WW; Xia M; Murray S; Curtis JL; Barr RG; Bhatt SP; Bleecker ER; Hansel NN; Cooper CB; Dransfield MT; Wells JM; Hoffman EA; Kanner RE; Paine R; Ortega VE; Peters SP; Krishnan JA; Bowler RP; Couper DJ; Woodruff PG; Martinez FJ; Martinez CH; Han MK
    Respir Med; 2018 Jul; 140():87-93. PubMed ID: 29957287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma N-terminal pro-brain natriuretic peptide: a prognostic marker in patients with chronic obstructive pulmonary disease.
    Chi SY; Kim EY; Ban HJ; Oh IJ; Kwon YS; Kim KS; Kim YI; Kim YC; Lim SC
    Lung; 2012 Jun; 190(3):271-6. PubMed ID: 22246552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
    Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL
    Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Blood Markers at Admission for Predicting Community Acquired Pneumonia in Chronic Obstructive Pulmonary Disease.
    Gao S; Duan Y; Chen J; Wang J
    COPD; 2021 Oct; 18(5):557-566. PubMed ID: 34511022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of nasal intermittent positive pressure ventilation on N-terminal pro-brain natriuretic peptide in patients with acute exacerbations of chronic obstructive pulmonary disease and type II respiratory failure].
    Wang Y; Yang Y; Chen P; Luo Y; Yang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 37(4):325-31. PubMed ID: 22561561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardized evaluation of lung congestion during COPD exacerbation better identifies patients at risk of dying.
    Høiseth AD; Omland T; Karlsson BD; Brekke PH; Søyseth V
    Int J Chron Obstruct Pulmon Dis; 2013; 8():621-9. PubMed ID: 24353412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac dysfunction in exacerbations of chronic obstructive pulmonary disease is often not detected by electrocardiogram and chest radiographs.
    Shafuddin E; Chang CL; Cooray M; McAnulty KA; Karalus NC; Lee MHS; Hancox RJ
    Intern Med J; 2019 Jun; 49(6):761-769. PubMed ID: 30324703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
    Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
    Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.